Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zimmer Holdings (NY:ZBH)

99.56 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zimmer Holdings

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
What Occidental Petroleum’s Latest Backer Sees in Oil’s Next Chapter
What Occidental Petroleum’s Latest Backer Sees in Oil’s Next Chapter 
Via The Motley Fool
Topics Energy Regulatory Compliance
1 Healthcare Stock to Research Further and 2 We Ignore
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This... 
Via StockStory
Topics Stocks
Q2 Earnings Roundup: CONMED (NYSE:CNMD) And The Rest Of The Surgical Equipment & Consumables - Diversified Segment
Let’s dig into the relative performance of CONMED (NYSE:CNMD) and its peers as we unravel the now-completed Q2 surgical equipment & consumables - diversified earnings season. 
Via StockStory
Topics Artificial Intelligence Economy
Earnings Scheduled For August 7, 2025
 
Via Benzinga
QSM Asset Management Takes $11.5 Million Stake in Rio Tinto, Expands Energy Exposure
Via The Motley Fool
QSM Asset Management Buys $6.8 Million of Pfizer Stock as Pharma Giant Lags Market
Via The Motley Fool
Demystifying Zimmer Biomet Holdings: Insights From 7 Analyst Reviews
 
Via Benzinga
2 Safe-and-Steady Stocks on Our Buy List and 1 That Underwhelm
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
Topics Bonds
3 Reasons to Avoid ZBH and 1 Stock to Buy Instead
Over the past six months, Zimmer Biomet’s stock price fell to $99.17. Shareholders have lost 12% of their capital, which is disappointing considering the S&P 500 has climbed by 24.7%. This might have... 
Via StockStory
Topics Stocks
Looking Into Zimmer Biomet Holdings Inc's Recent Short Interest
 
Via Benzinga
Expert Outlook: Zimmer Biomet Holdings Through The Eyes Of 5 Analysts
 
Via Benzinga
1 Value Stock for Long-Term Investors and 2 We Avoid
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few... 
Via StockStory
Intuitive Surgical's Stellar Q2 2025 Performance Propels Robotic Surgery Market Forward
Sunnyvale, CA – September 17, 2025 – Intuitive Surgical (NASDAQ: ISRG), the pioneer and global leader in robotic-assisted surgery, has once again demonstrated its formidable market position with a... 
Via MarketMinute
Topics Artificial Intelligence Supply Chain
Q2 Earnings Review: Surgical Equipment & Consumables - Diversified Stocks Led by Zimmer Biomet (NYSE:ZBH)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - diversified stocks fared... 
Via StockStory
Topics Artificial Intelligence Economy
The Dawn of a New Era: How GLP-1s, AI, and Robotic Surgery Are Reshaping Healthcare and Investment
The healthcare industry is currently experiencing a transformative "golden age," a period marked by an unprecedented surge in scientific breakthroughs and technological advancements. This era is... 
Via MarketMinute
Topics Artificial Intelligence Bankruptcy Economy
Surgical Equipment & Consumables - Diversified Stocks Q2 Highlights: STERIS (NYSE:STE)
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including STERIS (NYSE:STE) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy
1 Unpopular Stock That Deserves a Second Chance and 2 That Underwhelm
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
Surgical Equipment & Consumables - Diversified Stocks Q2 Teardown: Solventum (NYSE:SOLV) Vs The Rest
Let’s dig into the relative performance of Solventum (NYSE:SOLV) and its peers as we unravel the now-completed Q2 surgical equipment & consumables - diversified earnings season. 
Via StockStory
Topics Artificial Intelligence Economy
3 Mid-Cap Stocks Walking a Fine Line
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
Topics Economy
Surgical Equipment & Consumables - Diversified Stocks Q2 Results: Benchmarking BD (NYSE:BDX)
Let’s dig into the relative performance of BD (NYSE:BDX) and its peers as we unravel the now-completed Q2 surgical equipment & consumables - diversified earnings season. 
Via StockStory
Topics Artificial Intelligence Economy
Looking Into Zimmer Biomet Holdings's Recent Short Interest
 
Via Benzinga
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
Dip into a beaten-down market sector for deals on some proven winners. 
Via The Motley Fool
ZBH Q2 Deep Dive: New Product Launches and M&A Drive Guidance Upgrades
Medical device company Zimmer Biomet (NYSE:ZBH) announced better-than-expected revenue in Q2 CY2025, with sales up 7% year on year to $2.08 billion. Its non-GAAP profit of $2.07 per share was 4.8%... 
Via StockStory
Topics World Trade
A Glimpse Into The Expert Outlook On Zimmer Biomet Holdings Through 5 Analysts
 
Via Benzinga
Stay informed with the top movers within the S&P500 index on Thursday.
Let's delve into the developments on the US markets one hour before the close of the markets on Thursday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
Zimmer Biomet (NYSE:ZBH) Exceeds Q2 Expectations, Stock Soars
Medical device company Zimmer Biomet (NYSE:ZBH) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7% year on year to $2.08 billion. Its non-GAAP profit of $2.07 per share was 4.8%... 
Via StockStory
Zimmer Biomet's $2.08 Billion Q2 Sales Ignite Orthopedic Surge, Boosts Guidance Outlook
Zimmer Biomet beat Q2 estimates and raised its 2025 earnings forecast, driven by strong hip and knee sales, and new product momentum. 
Via Benzinga
Exploring the top movers within the S&P500 index during today's session.
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
Thursday's session: gap up and gap down stock in the S&P500 index
Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session. 
Via Chartmill
Zimmer Biomet (ZBH) Q2 Revenue Jumps 7%
Via The Motley Fool
Topics Economy
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.